|
|
Volumn 349, Issue 6244, 2015, Pages 129-
|
|
Cancer's copper connections
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
B RAF KINASE;
B RAF KINASE INHIBITOR;
CHELATING AGENT;
COPPER;
LYSYL OXIDASE LIKE 2;
OXIDOREDUCTASE;
UNCLASSIFIED DRUG;
BRAF PROTEIN, HUMAN;
COLLAGEN;
LOXL2 PROTEIN, HUMAN;
CANCER;
COPPER;
ANGIOGENESIS;
BREAST CANCER;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CARCINOGENESIS;
CLINICAL TRIAL (TOPIC);
HUMAN;
MELANOMA;
METASTASIS POTENTIAL;
NEOPLASM;
PHASE 1 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
ANTAGONISTS AND INHIBITORS;
CHEMISTRY;
GENETICS;
METABOLISM;
NEOPLASMS;
PATHOLOGY;
SKIN DISEASES;
AMINO ACID OXIDOREDUCTASES;
COLLAGEN;
COPPER;
HUMANS;
MELANOMA;
NEOPLASMS;
PROTO-ONCOGENE PROTEINS B-RAF;
SIGNAL TRANSDUCTION;
SKIN DISEASES;
|
|
EID: 84937440278
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.349.6244.129 Document Type: Short Survey |
|
Times cited : (27)
|
|
References (0)
|